Collaborative and Multidisciplinary Pilot Research (CaMPR) Pilot Award

This service is provided by the Pilot and Collaborative Studies Resource (PCSR) and Integrating Special Populations Resource (ISP).

Overview

The Collaborative and Multidisciplinary Pilot Research Pilot Award (CaMPR) focuses on the innovative assembly of new teams to gather preliminary data to address unresolved clinical, translational and public health problems with novel approaches informed by interdisciplinary and multidisciplinary collaboration. CaMPR’s goals are to: 

  1. support multi- and interdisciplinary research; 
  2. train and mentor a new generation of multidisciplinary, translational research investigators; 
  3. expand and optimize the utilization of outstanding new and existing resources at Columbia University; 
  4. support pilot work with the clear goal of submitting an NIH or other extramural proposal; and  
  5. support strategic areas of focus, including special populations (pediatrics, geriatrics, rare diseases, HIV), opioid research, and team science.

With these goals in mind, the CaMPR pilot award provides funding to support the formation of newly configured investigative teams aimed at addressing a significant health problem at the cellular, individual, or community level. Successful applicants are expected to implement plans to publish findings and to acquire future funding based on CaMPR award findings.  

  • Duration: One year
  • Award amount: $40,000
  • Number of awards: Up to five awards per year

Priority will be given to the following:

  • Projects that involve faculty collaborations from at least two of the four Columbia University Irving Medical Center (CUIMC) schools (Vagelos College of Physicians and Surgeons, College of Dental Medicine, School of Nursing, Mailman School of Public Health). Faculty/Investigators from New-York Presbyterian Hospital (non-MD health professionals) or a school from the Morningside or Manhattanville campuses may also apply, providing collaborators are from a CUIMC school. 
  • Projects that bring together faculty with expertise from diverse disciplines who have not previously been involved as co-investigators. 
  • Projects that are in novel areas for the principal investigator.
  • Projects that involve junior faculty members, preferentially serving as principal investigator. 
  • Projects focused on four special populations: Pediatrics, Geriatrics, Rare Diseases, or HIV. The Irving Institute’s Integrating Special Populations (ISP) supports the formation of newly-configured investigative teams aimed at studying diseases across the lifespan and utilizing rare diseases as tools to study more common ones, at CUIMC and within the community.  The ISP goals are to:  
    • Foster collaborations both within each special population and across special populations that will: 
      • Provide expertise necessary to study diseases across the lifespan  
      • Utilize rare diseases as tools to study more common diseases  
      • Increase the breadth of dissemination of the results of these efforts, with the goal of further increasing collaborations among investigators within and across the special populations  
    • Create culturally sensitive engagement, recruitment, and educational tools to facilitate ISP-based research in upper Manhattan 
  • Projects that involve community-based research. 
  • Projects that involve opioid research. 
  • Projects that involve team science (the study of team science). 

See a list of current and past CaMPR planning grant and pilot award recipients here.

Eligibility

  • Applicants (principal investigator(s)) must have a faculty appointment at CUIMC of assistant professor, associate research scientist or higher, in either the clinical or tenure track at the time of award. 
  • Postdoctoral fellows are not eligible to apply. 
  • Teams are limited to no more than six investigators. 
  • Although senior leaders of the Irving Institute may be consulted during the preparation of the application, they should not be listed as co-investigators or collaborators. 
  • Teams may include outside consultants with unique experience or expertise in innovative approaches not currently available at Columbia. 
  • During each application cycle, only one submission is permitted per principal investigator.   

Potential collaborators can be searched by keyword or by name through Columbia University Scientific Profiles (CUSP).

Deadlines

Applications are now being accepted. All applications must be submitted by Friday, December 13, 2019 at 5:00pm EST. 

For more information, see the 2020 CaMPR RFA. To apply, see the web-based application form.

Cite it, Submit it, Share it!

If your research has benefited from one or more Irving Institute resources, please remember to:

  • Cite our CTSA grant, UL1 TR001873, in any relevant publications, abstracts, chapters, and/or posters.
  • Submit your publications to PubMed Central (PMC) for compliance with the NIH Public Access Policy.
  • Share your research updates with us by sending an email to: irving_institute@cumc.columbia.edu

Contact

Helena Rincon
622 West 168th Street, 10th Floor
New York, NY 10032
United States